M42 launches AI kidney health assistant
kidney.com wants to keep kidney patients out of hospital
#UAE #HealthTech — Abu Dhabi-based global health company M42 and its world-leading renal care business, Sweden-headquartered Diaverum, have launched kidney.com, a free AI-powered kidney health education platform. Built on a conversational AI interface trained on clinical sources and shaped by more than 30 nephrologists across 13 countries, the platform delivers personalised, evidence-based kidney health education at no cost to users. The goal is straightforward: better-informed patients get hospitalised less, visit emergency departments less, and manage their conditions more effectively. The platform is now accessible in the UAE, France, Germany, Portugal, and the UK.
SO WHAT? — Chronic kidney disease is one of the fastest-growing and most expensive conditions facing health systems globally. In Europe alone it costs an estimated €140 billion annually. In the UAE, between 4% and 5% of adults are affected, with prevalence rising sharply with age. The GenAI platform kidney.com is a direct response to a well-documented problem: most patients lack accessible, trustworthy information about their condition until it is already serious. An AI platform that closes that gap at scale could materially shift outcomes across multiple health systems simultaneously. kidney.com does this at no cost and is now available as a resource to millions.
KEY POINTS:
G42’s global health company M42 and its global renal care business, Diaverum, have launched kidney.com, a free AI-powered kidney health education assistant, available from day one in the UAE, France, Germany, Portugal, and the UK, with further markets to follow. The platform is accessible around the clock and designed to complement, not replace, clinical care.
The platform was built with serious clinical rigour. More than 30 nephrologists, physicians, and nurses across 13 countries contributed to its development, and the system completed over 14,000 chat interactions during testing before going live.
kidney.com uses a conversational AI interface trained on trusted clinical sources to deliver personalised, evidence-based education that adapts to each user’s specific needs and knowledge level, making complex renal health information accessible to a general audience.
The platform launches with multilingual support across five languages: English, Arabic, French, German, and Portuguese. Additional languages are under development. It also supports voice control and product label interpretation via file upload, broadening accessibility for diverse user groups.
The clinical and economic case for patient education is well established. Studies consistently show that well-informed patients are less likely to be hospitalised or to visit emergency departments, directly reducing pressure on health systems managing the costs of chronic disease.
kidney.com is clinically specialised, not a general AI tool. It is not a medical device and is not designed to diagnose or recommend treatment. Its purpose is to support informed self-management and foster better conversations between patients and their clinical teams.
The scale of the problem kidney.com is targeting is significant. Chronic kidney disease costs European health systems an estimated €140 billion per year. In the UAE, prevalence among adults is estimated at 4% to 5%, rising steeply with age — figures that reinforce the urgency of early education and prevention.
The launch is in line with M42’s broader strategic direction to build the next-generation healthcare infrastructure powered by AI, data, and genomics.
ZOOM OUT — Part of Abu Dhabi-based AI holding and investment group G42, Med42 is a pioneer in the research and development of advanced AI healthcare platforms. The company previously developed its own clinically-aligned large language model, which was downloaded thousands of times by researchers and medical institutions.
[Written and edited with the assistance of AI]
Read more about M42 and AI:
Abu Dhabi launches global digital health Innovation Hub (Middle East AI News)
M42 releases MEDIC to benchmark clinical LLMs (Middle East AI News)
M42 delivers framework for evaluating clinical LLMs (Middle East AI News)
M42 releases new versions of clinical LLM (Middle East AI News)